Dr. Pranshu Bansal, MD

Dr. Bansal practices at Ironwood Cancer & Research Centers in Mesa, Arizona.

Dr. Bansal's NPI, 1447548722, was assigned on July 20, 2011. Dr. Bansal holds Arizona license 62505.

Dr. Bansal's primary practice is Ironwood Cancer & Research Centers, at 6111 E Arbor Ave, Mesa, AZ 85206 in Maricopa County. The practice phone is (480) 821-2838.

Dr. Bansal's primary practice is Ironwood Cancer & Research Centers in Mesa, Arizona. Dr. Bansal is also affiliated with Banner Baywood Medical Center. The medical group on file is Ironwood Cancer & Research Centers. Dmand AI also links Dr. Bansal to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bansal practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bansal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bansal is licensed in Arizona.

CMS data shows 167,776 Medicare services from Dr. Bansal across 60 procedure codes in 2024, for 635 Medicare patients. Medicare paid $1,721,096 for them.

CMS counts 635 Medicare patients who saw Dr. Bansal in 2024. The largest group is 75 to 84, with 283 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bansal's median patient age at 70, with 56% women.

In 2024, Dr. Bansal wrote 1,702 Medicare Part D claims for 291 patients. 75% of them were for generic drugs. CMS names the drug for 1,465 of them, across 38 drugs with 11 or more claims each, at $3,552,914 in total drug cost. In 2023, CMS named 1,627 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Bansal for performance year 2024. Dr. Bansal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bansal as offering telehealth.

Dmand AI links 14 papers to Dr. Bansal, published from 2015 to 2023. 2016 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Bone Marrow and Carcinoma, Hepatocellular. Dr. Bansal has published most often in Clin Case Rep. Dr. Bansal's most frequent co-authors are Gregory N. Gan, MD, PhD, Diaa Osman, DO and Yehuda Z. Patt, MD.

Dmand AI links Dr. Bansal to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 947 general payments to Dr. Bansal from 74 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $32,142.